Alexandria Real Estate Equities
ARE
#2192
Rank
HK$65.09 B
Marketcap
HK$375.64
Share price
1.54%
Change (1 day)
-48.11%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -HK$7.71 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are HK$2.94 Billion. a decrease over its 2024 earnings that were of HK$5.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 -HK$7.75 Billion-242.13%
2024 HK$5.45 B96.11%
2023 HK$2.77 B-53.56%
2022 HK$5.98 B-3.96%
2021 HK$6.23 B-20.26%
2020 HK$7.81 B72.88%
2019 HK$4.52 B3.11%
2018 HK$4.38 B73.54%
2017 HK$2.52 B464.88%
2016 HK$0.44 B-77.32%
2015 HK$1.97 B36.31%
2014 HK$1.44 B-10.81%
2013 HK$1.62 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$79.74 B-1,129.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$201.32 B-2,699.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$70.23 B-1,006.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$76.65 B-1,089.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$9.27 B-219.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$72.98 B-1,042.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$4.50 B-158.16%๐Ÿ‡บ๐Ÿ‡ธ USA